Please try another search
HLB PANAGENE Co., LTD. develops products in the field of molecular diagnostics in South Korea. Its products include liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products. The company was formerly known as Panagene Inc. and changed its name to HLB PANAGENE Co., LTD. in August 2023. HLB PANAGENE Co., LTD. was incorporated in 1976 and is based in Daejeon, South Korea.
Name | Age | Since | Title |
---|---|---|---|
Joon-Byung Park | 62 | - | Independent Outside Director |
June-Gone Park | 72 | - | Director |
Jae-Ho Kwon | 59 | - | Director |
Sung-Eun Yoo | 71 | - | Independent Outside Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review